BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
To help improve the quality of breast cancer care globally, a collaboration of leading partners has created the Grand Rounds in Breast Cancer series of educational webinars. This session with ecancer enables learners the opportunity to discuss controversies, real-life challenges and effective application of existing knowledge.
In this edition Dr Marjanka Schmidt (Netherlands Cancer Institute, Amsterdam, Netherlands) presents her talk on'Insights into germline genetic screening of breast cancer patients' before fielding questions from Dr Seigo Nakamura (Showa University, Tokyo, Japan).
Dr Teresa Ramón y Cajal (Hospital Clinic of Barcelona, Barcelona, Spain) chairs the webinar and also joins Dr Schmidt and Dr Nakamura in the discussion.
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
AI-Based sTIL analysis expands identification of HER2+ BC patients benefiting from pertuzumab
The added value of integrative medicine
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Best practice in HRRm testing in patients with metastatic prostate cancer
Multiple myeloma in a resource constrained setting
Genomic testing: Awareness and effective communication between healthcare professionals and patients
Advancing breast cancer treatment in Uganda by improving molecular testing
Somatic mutation profile of breast cancer in Uganda